Sienna Senior Living Inc header image

Sienna Senior Living Inc

SIA

Equity

ISIN null / Valor 28093100

Toronto Stock Exchange (2026-02-23)
CAD 23.89+4.14%

Sienna Senior Living Inc
UMushroom community rating:

star star star star star
0.00 0 votes No rating yet
NegativeNeutralPositive

About company

Sienna Senior Living Inc. is a prominent Canadian company specializing in senior living and long-term care services. The company operates a network of retirement residences and long-term care facilities across Canada, providing a range of services tailored to the needs of seniors. These services include independent living, assisted living, and specialized care for individuals with complex health needs. Sienna Senior Living is committed to enhancing the quality of life for its residents through comprehensive care and support. The company also engages in initiatives to support healthcare professionals, such as offering loans and mentorship programs for internationally-trained professionals seeking Canadian accreditation. Through its diverse offerings, Sienna Senior Living aims to create a supportive and engaging environment for seniors, promoting their well-being and social interaction.

Summarized from source with an LLMView SourceSector: Healthcare

Latest Results (23.01.2026):

Sienna Senior Living Inc — Q4 2024: Sienna reported strong Q4 2024 and full‑year 2024 results with broad operational and financial improvement. Total adjusted revenue for Q4 rose to $246.3M (+12.5% YoY), total adjusted NOI was $46.7M (+22.1% YoY) and adjusted same‑property NOI grew 22.6% YoY (29.0% in long‑term care and 15.3% in retirement). Net income for Q4 was $7.86M (vs. $0.43M a year earlier). Retirement same‑property occupancy reached 92.9% in Q4 (up 300 bps YoY) and the company strengthened its balance sheet with a $144M equity raise and $150M of unsecured debentures issued in 2024.

Revenue and NOI

Q4 2024 total adjusted revenue: $246.3M (vs $218.9M Q4 2023). Q4 total adjusted NOI: $46.7M (vs $38.2M). Same‑property NOI growth in Q4 2024: total +22.6% YoY, LTC +29.0%, Retirement +15.3%.

Profitability and cash‑flow metrics

Adjusted EBITDA for Q4 2024: $38.6M (vs $31.3M). Net income Q4: $7.86M (vs $0.43M). OFFO (operating FFO) Q4: $29.43M and AFFO Q4: $25.08M; AFFO per share $0.304. Dividends declared in Q4: $19.33M (dividend per share $0.234). AFFO payout ratio for Q4 2024: 77.1%.

Occupancy and operations

Retirement same‑property occupancy (Q4 2024): 92.9% (up 110 bps vs Q3 2024 and +300 bps YoY). LTC average occupancy remained very high (total 98.4% in Q4). Company expects to reach a stabilized retirement occupancy target of 95% within ~12 months and forecasts 2025 margin expansion of ~100–150 bps versus 2024.

Balance sheet and liquidity

Debt to adjusted gross book value at Q4 2024: 41.1% (down from 44.6% a year ago). Debt/Adjusted EBITDA: 6.4x (improved from 8.4x). Interest coverage about 3.4x and debt service coverage ~2.0x. 2024 liquidity actions included a $144M equity raise and issuance of $150M unsecured debentures to refinance maturing debt.

One‑time items and normalization

Sienna recognized $29.5M of one‑time items in 2024 (including Ontario one‑time funding, BC retroactive funding and a WSIB refund); net of tax these reduced to ~$21.7M. Excluding one‑time items, normalized Q4 and full‑year performance remains meaningfully improved versus 2023.

Growth pipeline and acquisitions

Sienna is advancing redevelopment projects (two expected completed and operational in H2 2025 with expected investment yields of 8.0–8.5%) and reports nearly $300M of accretive acquisitions under contract. The company also closed a strategic portfolio acquisition in Alberta as part of geographic expansion.

Asset optimization and portfolio initiatives

The company identified five retirement residences for near‑term repositioning (current average occupancy ~76%) to improve market fit and unlock NOI growth. Retirement assets undergoing optimization were moved out of the same‑property pool into a Growth & Optimization portfolio.

People and outlook

Sienna reported improved team retention (turnover down ~30% for a second consecutive year) supporting operational stability. Management remains constructive on sector fundamentals (aging population, constrained supply) and expects continued NOI and margin growth in 2025 driven by occupancy gains, asset optimization, redevelopments and accretive acquisitions.

Summarized from source with an LLMView Source

Key figures

55.6%1Y
93.6%3Y
77.2%5Y

Performance

18.8%1Y
19.4%3Y
19.4%5Y

Volatility

Market cap

1636 M

Market cap (USD)

Daily traded volume (Shares)

427,546

Daily traded volume (Shares)

1 day high/low

15.8 / 15.42

1 day high/low (USD)

52 weeks high/low

0.00 / 0.00

52 weeks high/low (USD)

Dividend ex-date

01 January, 2022

Dividend ex-date

Dividend

0.00

Dividend (USD)

Dividend yield (p.a.)

0.00%

Dividend yield (p.a.)

0.002022
0.002023
0.002024

Est dividend (USD)

0.00%2022
0.00%2023
0.00%2024

Est dividend yield

P/E ratio

10.00

P/E ratio

00.002022
00.002023
00.002024

Est P/E ratio

EPS

0.00

EPS (USD)

0.002022
0.002023
0.002024

Est EPS (USD)

Ratings & reviews

star star star star star

0.00

0 votes
Performance:
starstarstarstarstar
0.00
Innovation:
starstarstarstarstar
0.00
Society:
starstarstarstarstar
0.00
Nature:
starstarstarstarstar
0.00

EQUITIES OF THE SAME SECTOR

AstraZeneca PLC
AstraZeneca PLC AstraZeneca PLC Valor: 982352
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
0.48%GBP 153.44
Estee Lauder Companies Inc
Estee Lauder Companies Inc Estee Lauder Companies Inc Valor: 99350
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-1.06%USD 113.02
Humana Inc
Humana Inc Humana Inc Valor: 940174
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-4.57%USD 181.16
Summit Therapeutics Inc
Summit Therapeutics Inc Summit Therapeutics Inc Valor: 56903013
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
0.94%USD 16.09
Amgen Inc
Amgen Inc Amgen Inc Valor: 907582
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
1.25%USD 379.42
Intuitive Surgical Inc
Intuitive Surgical Inc Intuitive Surgical Inc Valor: 1631646
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-2.37%USD 492.10
Takeda Yakuhin Kogyo KK
Takeda Yakuhin Kogyo KK Takeda Yakuhin Kogyo KK Valor: 11292411
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
0.75%USD 18.80
Centene Corp
Centene Corp Centene Corp Valor: 1313733
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
0.23%USD 43.34
Tilray Brands Inc
Tilray Brands Inc Tilray Brands Inc Valor: 42386407
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-2.58%USD 7.55
Syndax Pharmaceuticals Inc
Syndax Pharmaceuticals Inc Syndax Pharmaceuticals Inc Valor: 24112479
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
1.07%USD 19.90